Jan Eckermann, MD
Neurological Surgery · Bakersfield, CANPI 1962619668
Payments from drug & device makers
Across 742 payments — averaging $104.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$41K
- Medtronic$17K
- Boston Scientific$15K
- Abbott$3K
- Globus Medical$897
- Saluda Medical Americas, Inc.$529
- plus $459 from 5 others
Across 5 payments — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$15K
What the payments were for
- Speaking & faculty fees$34,87553%
- Travel & lodging$2,8544%
- Food & beverage$28,46743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 206 | $41,400 |
| Medtronic(2 entities) | 341 | $16,973 |
| Boston Scientific | 104 | $14,852 |
| Abbott | 58 | $2,786 |
| Globus Medical(2 entities) | 21 | $897 |
| Saluda Medical Americas, Inc. | 5 | $529 |
| Nalu Medical, Inc. | 3 | $182 |
| Si-bone, Inc. | 1 | $143 |
| Smith+Nephew | 1 | $47 |
| Mimedx Group, Inc. | 1 | $47 |
| Exelixis Inc. | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$22,151
- PRECISION$9,625
- INTELLIS ADAPTIVESTIM$3,320
- GENERAL - THERAPIES$2,750
- Omnia$1,660
- INTELLIS$884
- Proclaim Family of SCS IPGs$658
- INCEPTIV$408
- Evoke$406
- Senza$291
- Proclaim IPG$245
- Protege Family of SCS IPGs$153
- SPECTRA WAVEWRITER$150
- iFuse Implant$143
- GENERAL PAIN MANAGEMENT$125
- Penta SCS Leads$119
How this compares
$77,896 in reported general payments places this provider in the 80th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 18 | $164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Bakersfield
- Geoffrey ManleySan Francisco$24.9M
- Christopher AmesSan Francisco$7.1M
- Jamshid SalehRedding$4.1M
- Bruce McCormackSan Francisco$3.9M
- Andrew SchreiberSanta Ana$3.9M
- Larry KhooLos Angeles$3M
- Jennie TaylorSan Francisco$2.7M
- Joseph CiacciSan Diego$2.6M
- Nicholas ButowskiSan Francisco$2.4M
- Samy AbdouSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.